We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00982670
First Posted: September 23, 2009
Last Update Posted: September 23, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Far Eastern Memorial Hospital
September 22, 2009
September 23, 2009
September 23, 2009
July 2008
December 2008   (Final data collection date for primary outcome measure)
The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in Taiwan [ Time Frame: One year ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
Association of the Metabolic Syndrome and Systemic Lupus Erythematosus in Taiwan
An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.
This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Stored serum
Non-Probability Sample
Persons aged 18 and above.
  • Metabolic Syndrome
  • Cardiovascular Risk Factors
  • Systemic Lupus Erythematosus
Not Provided
  • Systemic lupus erythematosus
    Patients should fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus
  • Normal control
    Age- and sex-matched health volunteers will serve as controls.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
June 2009
December 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Persons aged 18 and above.
  • Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.

Exclusion Criteria:

  • Exclude a history myocardial infarction, angina or stroke.
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT00982670
FEMH-96-D-032
Yes
Not Provided
Not Provided
Chun-Chen Yang, Far Eastern Memorial Hospital
Far Eastern Memorial Hospital
Not Provided
Principal Investigator: Chun-Chen Yang, MD Far Eastern Memorial Hospital
Far Eastern Memorial Hospital
September 2009